Abstract

Background Diabetic kidney disease (DKD) is a common microvascular chronic complication affecting approximately 40% of patients with diabetes mellitus (DM). DKD is one of the major causes of kidney failure in many countries, and is associated with increased health system costs. Kidney transplantation is the treatment of choice for a significant portion of patients with end-stage kidney disease, including DM patients. In this context, acute rejection (AR) is a major post-transplant complication. The use of biomarkers as a method to prognosticate or detect early pathologic events in kidney transplantation is an attractive and needed strategy. Several studies have evaluated the relevance of genetic variants, including the K121Q polymorphism (rs1044498) in the ENPP1 gene, as predictors for the development of diabetes, DKD and, more recently, AR in kidney transplantation.

Highlights

  • Diabetic kidney disease (DKD) is a common microvascular chronic complication affecting approximately 40% of patients with diabetes mellitus (DM)

  • K121Q snp of ENPP1 gene is associated with acute rejection in kidney transplantation

  • Kidney transplantation is the treatment of choice for a significant portion of patients with end-stage kidney disease, including DM patients

Read more

Summary

Introduction

Diabetic kidney disease (DKD) is a common microvascular chronic complication affecting approximately 40% of patients with diabetes mellitus (DM). K121Q snp of ENPP1 gene is associated with acute rejection in kidney transplantation Denise Alves Sortica*, Bruna Bellincanta Nicoletto, Pâmela Sachs Nique, Laura Bem Olivo, Evylyny Gomes Malaquias, Andrea Carla Bauer, Daisy Crispim, Roberto Ceratti Manfro, Luis Henrique Canani From 20th Brazilian Diabetes Society Congress Porto Alegre, Brazil.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.